Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
Joe and Kyle discuss recent news items, including a new LSD microdose study on acute pain, Compass Pathways filing an application for a NASDAQ listing, and Mind Medicine Australia attempting to de-schedule psilocybin and MDMA.